LOGIN  |  REGISTER
Assertio

Latest Health Technology Stock News

Phreesia Announces Third Quarter Fiscal 2025 Results

December 9
Last Trade: 23.57 1.94 8.97

ALL-REMOTE COMPANY/WILMINGTON, Del. / Dec 09, 2024 / Business Wire / Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2024. "We are excited about the future here at Phreesia,” said CEO and Co-Founder Chaim Indig. “Our network continues to grow, adoption of our current offerings is increasing, and we are beginning to see the promise of new solutions we...Read more


HealthEquity Reports Third Quarter Ended October 31, 2024 Financial Results

December 9
Last Trade: 94.92 -6.08 -6.02

Highlights of the third quarter include: Revenue of $300.4 million, an increase of 21% compared to $249.2 million in Q3 FY24. Net income of $5.7 million, compared to $14.7 million in Q3 FY24, with non-GAAP net income of $69.4 million, an increase of 33% compared to $52.2 million in Q3 FY24. Net income per diluted share of $0.06, compared to $0.17 in Q3 FY24, with non-GAAP net income per diluted share of...Read more


Omnicell Announces OmniSphere

December 9
Last Trade: 47.29 0.19 0.40

Next-generation, cloud native, software workflow engine and data platform intended to seamlessly integrate enterprise robotics and smart devices across the continuum of care Company Showcases New and Enhanced Outcomes-Centric Innovation at ASHP Midyear 2024 FORT WORTH, Texas / Dec 09, 2024 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery...Read more


NetraMark Signs A Pilot Collaboration Agreement With A Top 5 Pharmaceutical Company

December 9
Last Trade: 0.93 -0.07 -7.00

TORONTO, Dec. 9, 2024 /CNW/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: 8TV) a premier artificial intelligence (AI) company that is transforming clinical trials in the pharmaceutical industry, is proud to announce that it has entered into a pilot collaboration agreement with a Top 5 pharmaceutical company. The pilot is seeking to unlock novel insights and hypotheses regarding...Read more


Veeva Systems Announces Fiscal 2025 Third Quarter Results

December 5
Last Trade: 247.62 1.62 0.66

Total Revenues of $699.2M, up 13% Year Over Year Subscription Services Revenues of $580.9M, up 17% Year Over Year PLEASANTON, Calif., Dec. 5, 2024 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its third quarter ended October 31, 2024. "It was a great quarter of innovation and excellent execution across the...Read more


GE HealthCare Expands Its Effortless Recon DL Portfolio, Bringing Advanced Deep Learning Image Reconstruction to Clinicians Worldwide

December 5
Last Trade: 81.90 0.00 0.00

More than 80 percent of all health system visits include an imaging exam,i making radiology an essential part of diagnostics and healthcare and image quality a cornerstone of medicine. GE HealthCare is at the forefront of leveraging deep learning, a subset of artificial intelligence (AI), to benefit clinicians and patients with the latest technologies and solutions. CHICAGO / Dec 05, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC)...Read more


GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners

December 5
Last Trade: 72.60 -0.26 -0.36

STAMFORD, Conn. / Dec 05, 2024 / Business Wire / GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines (Nasdaq: PRAX) and Stoke Therapeutics (Nasdaq: STOK) as the founding partners to its Patient Access Program for pediatric epilepsy, which provides access to whole exome sequencing. Currently, access to a definitive genetic diagnosis...Read more


GE HealthCare showcases commitment to sustainable innovation at RSNA 2024

December 4
Last Trade: 81.90 0.00 0.00

Determined to reach net zero emissions by 2050, GE HealthCare’s portfolio features environmentally conscious product design, energy efficiency, and technology circularity while continuing to drive advancements in patient care CHICAGO / Dec 04, 2024 / Business Wire / As part of a companywide commitment to advance innovation that improves the health of patients and the planet, GE HealthCare (Nasdaq: GEHC) is highlighting several...Read more


GE HealthCare announces 510(k) submission for CleaRecon DL technology designed to improve image quality in the interventional suite with AI-based reconstruction

December 3
Last Trade: 81.90 0.00 0.00

CleaRecon DL* is designed to improve cone-beam computed tomography (CBCT) image quality by removing streaks and help clinicians improve their confidence in image interpretation when analyzing CBCT data CHICAGO / Dec 03, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) announced today the 510(k) submission to the U.S. Food and Drug Administration for CleaRecon DL, deep learning technology, designed to improve the quality of cone-beam...Read more


HEALWELL AI Acquires Control of Mutuo Health Solutions to Build Next Generation of AI-Powered Physician Co-Pilots

December 3
Last Trade: 1.88 0.03 1.62

HEALWELL has acquired a majority controlling interest in Mutuo Health Solutions, a Toronto-based medical artificial intelligence company focused on developing predictive clinical AI technology. Mutuo Health's AutoScribe platform is an advanced AI-powered ambient scribe solution that transcribes clinician-patient interactions into high-quality electronic medical records in real time using natural language processing and machine learning...Read more


Premier Appoints David Zito as President, Performance Services

December 3
Last Trade: 21.81 -0.02 -0.09

CHARLOTTE, N.C. / Dec 03, 2024 / Business Wire / Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that it has named David (Dave) Zito as President, Performance Services, effective December 6, 2024. Zito will oversee Premier’s Performance Services segment, including the continued development and growth of the company’s enterprise-wide, AI-enabled technology businesses and Premier’s...Read more


Certara Showcases 2024 Research Wins With Over 100 Papers Published

December 2
Last Trade: 11.60 0.09 0.78

RADNOR, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today showcases its impact on research by celebrating more than 100 publications secured in 2024 as well as the 12 Certara scientists included on the 2024 Stanford/Elsevier list, which highlights the top 2% of the most cited scientists across the globe. Stanford/Elsevier's Top 2% Scientist Ranking Now in its...Read more


OneMedNet Announces Exciting New Collaboration with Bayer's AI Innovation Platform to Help Accelerate Healthcare AI Development

December 2
Last Trade: 0.96 0.04 4.13

MINNEAPOLIS, Dec. 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), a Real-World Data (RWD) platform — has announced its collaboration with Bayer's AI Innovation Platform (AIIP). By joining AIIP, the partnership aims to empower the developer teams of healthcare organizations and startups in building scalable and compliant AI-powered medical imaging software products. "We are thrilled to...Read more


GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical

December 1
Last Trade: 81.90 0.00 0.00

GE HealthCare to acquire 50% stake from Sumitomo Chemical to assume full ownership of NMP, subject to regulatory approvals As part of GE HealthCare, NMP, already a leading radiopharmaceutical company in Japan, will enhance patient access to next-generation radiopharmaceuticals that enable detection and diagnosis of disease Acquisition positions NMP to become partner of choice for global innovators looking to bring novel...Read more


GE HealthCare Unveils Sonic DL for 3D, Expanding Deep Learning Innovations in MRI

December 1
Last Trade: 81.90 0.00 0.00

New 3D imaging capabilities of Sonic DL are designed to enable up to 86%i faster scans and enhanced resolution for brain, spine, orthopedic and body imaging. Combination of Sonic DL and AIR Recon DL accelerates workflow while improving diagnostic confidence and patient comfort. CHICAGO / Dec 01, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today unveiled Sonic DL for 3Dii, the newest addition to its effortless imaging...Read more


GE HealthCare Highlights New Solutions Including AI-enabled Innovations to Drive Precision Care at RSNA 2024

December 1
Last Trade: 81.90 0.00 0.00

Booth (#7330) will showcase new innovations that address the most pressing challenges in healthcare, spanning the care journey across devices, disease states and digital tools New product introductions reflect GE HealthCare’s increased R&D investment since 2022 CHICAGO / Dec 01, 2024 / Business Wire / At the Radiological Society of North America’s (RSNA) 2024 Annual Meeting taking place from Dec. 1-4 in Chicago, GE HealthCare...Read more


Mobile-health Network Solutions to Present at Noble Capital Markets’ Twentieth Annual Emerging Growth Equity Conference on December 3-4, 2024

November 27
Last Trade: 0.34 -0.0046 -1.35

SINGAPORE, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”), a leading Asia-Pacific telehealth provider, today announced that its Co-founders and Co-CEOs, Dr. Rachel Teoh, and Dr. Siaw Tung Yeng, will present at NobleCon20 - Noble Capital Markets’ Twentieth Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca...Read more


Newtopia Reports Third Quarter 2024 Financial Results

November 27
Last Trade: 0.005 0.00 0.00

We are well-positioned to grow via key market opportunities at the forefront of global healthcare, including the incoming U.S. administration's aim to "Make America Healthy Again" by tackling chronic disease. Commercial and Community Care-Delivery: Continued expansion with market-leading employer, provider and payvider innovation partners Growth of GLP-1s: Engagement expertise provides unique ability to facilitate sustainable...Read more


iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024

November 26
Last Trade: 1.89 0.01 0.53

NASHUA, N.H., Nov. 26, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”), a global leader in clinically proven AI-powered cancer detection solutions, will showcase its groundbreaking breast health AI technologies at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago, December 1-5. Key highlights include the recent FDA-cleared ProFound Detection Version 4, clinical research...Read more


GE HealthCare unveils Pristina Via to streamline technologist workflow and improve patient-centered breast care

November 26
Last Trade: 81.90 0.00 0.00

Amid technologist shortage, new mammography innovation was designed through intensive collaboration with technologists will help to streamline workflow and humanize care CHICAGO / Nov 26, 2024 / Business Wire / Today GE HealthCare announced the new Pristina Via™* mammography system designed to enhance the screening experience for both technologists and patients. Debuting at the Radiological Society of North America’s 2024 Annual...Read more


GE HealthCare management to present at upcoming investor conferences

November 25
Last Trade: 81.90 0.00 0.00

CHICAGO / Nov 25, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences. Nasdaq Investor Conference in London, England - December 10, 2024 at 11:00 am GMT / 5:00 am CT / 6:00 am ET 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA - January 14, 2025 at 4:15 pm CT / 5:15 pm ET Webcasts of these events can be...Read more


Teladoc Health Expands AI Capabilities for Hospitals and Health Systems with Advanced Virtual Sitter Solution

November 25
Last Trade: 10.70 0.01 0.09

PURCHASE, NY, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, announced today the launch of new AI-enabled capabilities to enhance its Virtual Sitter solution to improve patient safety, address workforce challenges, and enhance care delivery for hospitals and health systems. Every year, nearly 1 million hospitalized patients experience falls, with more than 30% resulting in lasting...Read more


Veeva Systems Announces AI in Vault CRM

November 24
Last Trade: 247.62 1.62 0.66

CRM Bot and Voice Control deliver GenAI-powered assistance in Vault CRM SINGAPORE, Nov. 24, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Vault CRM Bot and Vault CRM Voice Control, two new GenAI capabilities in Vault CRM. Unveiled at Veeva Commercial Summit Europe, CRM Bot and Voice Control join a host of new innovations coming to Vault CRM next year. With these new capabilities, companies can deploy AI that will...Read more


Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference

November 22
Last Trade: 47.29 0.19 0.40

FORT WORTH, Texas / Nov 22, 2024 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024 at 2:00 p.m. ET. Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/ About Omnicell Since...Read more


GE HealthCare Announces Advanced Imaging Innovations for OEC 3D C-arm to Help Improve Precision Care in Practice of Interventional Pulmonology

November 22
Last Trade: 81.90 0.00 0.00

To help improve clinician workflow and visualization during endoscopic bronchoscopy procedures, the company has added Lung Suite to their OEC 3D m-CBCT offering. OEC Open interface expanded with additional third-party option to streamline data interface during bronchoscopy procedures. CHICAGO / Nov 22, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) announces additional clinical applications now available as part of the OEC 3D...Read more


GE HealthCare hosts 2024 Investor Day: focus on innovation to deliver precision care and drive growth

November 21
Last Trade: 81.90 0.00 0.00

Company updates medium-term framework with progress toward financial goals; increases quarterly cash dividend by approximately 17% CHICAGO / Nov 21, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) will host its Investor Day today at Nasdaq MarketSite in New York, NY. The event begins at 8:00 am ET / 7:00 am CT and can be viewed virtually here. Registration is required for in-person attendance. The event will feature presentations...Read more


SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024

November 21
Last Trade: 3.36 0.0008 0.02

Launch of new application enables global access to highly recognized solid tumor profiling assay BOSTON and ROLLE, Switzerland, Nov. 21, 2024 /CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, announced the global launch of MSK-IMPACT® powered with SOPHiA DDM™ today from the Association for Molecular Pathology (AMP) Annual Meeting. This innovative solution provides...Read more


Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference

November 20
Last Trade: 22.06 0.38 1.75

NEW YORK / Nov 20, 2024 / Business Wire / Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference. The live presentation will take place on Wednesday, December 4, 2024 at 8:30 a.m. ET. The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days following the...Read more


Health Catalyst Launches AI-Enabled Cyber Protection Product for Healthcare

November 20
Last Trade: 8.39 0.05 0.60

SALT LAKE CITY, Nov. 20, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of an AI-powered version of BluePrint Protect™ from Intraprise Health, LLC ("Intraprise Health"), a platform that empowers healthcare organizations to screen and identify risks related to cybersecurity...Read more


VitalHub announces SHREWD implementation with Winnipeg Regional Health Authority

November 20
Last Trade: 11.22 -0.29 -2.52

TORONTO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has successfully completed an implementation of its regional patient flow and whole-system visibility platform, SHREWD, to support improved patient flow and safer, more effective care coordination. SHREWD is a real-time operational management platform which supports – and gathers data from –...Read more


Veeva Systems Announces AI in Vault CRM

November 20
Last Trade: 247.62 1.62 0.66

CRM Bot and Voice Control deliver GenAI-powered assistance in Vault CRM MADRID and PLEASANTON, Calif., Nov. 20, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Vault CRM Bot and Vault CRM Voice Control, two new GenAI capabilities in Vault CRM. Unveiled at Veeva Commercial Summit Europe, CRM Bot and Voice Control join a host of new innovations coming to Vault CRM next year. With these new capabilities,...Read more


SCWorx Announces Completion of Equity Financing with Institutional Investors

November 20
Last Trade: 1.94 -0.11 -5.15

New York, NY, Nov. 20, 2024 (GLOBE NEWSWIRE) -- SCWorx Corp (the “Company”), on November 19th, 2024 completed an equity financing with institutional investors (the “Institutional Investors” or “Investors”). In connection with the funding, the Company sold an aggregate of 232,558 shares of common stock and warrants to purchase the same number of shares of common stock, for aggregate gross proceeds of $200,000. The Company will be...Read more


So-Young Reports Unaudited Third Quarter 2024 Financial Results

November 20
Last Trade: 0.81 -0.06 -6.93

BEIJING, Nov. 20, 2024 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights Total revenues were RMB371.8 million...Read more


GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover

November 19
Last Trade: 72.60 -0.26 -0.36

New Biopharma Solution Aims to Accelerate the Delivery of Precision Medicine to More Patients STAMFORD, Conn. / Nov 19, 2024 / Business Wire / GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced GeneDx Discover, a first-of-its-kind data visualization tool, which provides biopharmaceutical companies access to deidentified and aggregated genetic data - powered by GeneDx’s robust...Read more


Veeva Systems Announces New Digital Hazard Analysis and Critical Control Point (HACCP) Solution

November 19
Last Trade: 247.62 1.62 0.66

PLEASANTON, Calif., Nov. 19, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced its new cloud-based digital Hazard Analysis and Critical Control Point (HACCP) solution. Delivering HACCP management as part of the Veeva QualityOne Suite will help food and beverage manufacturers streamline food safety and quality processes, improve visibility and control over critical risks, and enable proactive quality management and compliance...Read more


Omnicell Announces Proposed Private Placement of $150 Million of Convertible Senior Notes

November 18
Last Trade: 47.29 0.19 0.40

FORT WORTH, Texas / Nov 18, 2024 / Business Wire / Omnicell, Inc. (NASDAQ: OMCL) (“Omnicell”) today announced that it intends to offer, subject to market conditions and other factors, $150.0 million aggregate principal amount of Convertible Senior Notes due 2029 (the “notes”) in a private placement (the “offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as...Read more


GE HealthCare Pilot Study Showcases the Value of Portrait Mobile Continuous Monitoring Solution to Encourage Clinical Intervention While Mitigating Alarm Fatigue

November 18
Last Trade: 81.90 0.00 0.00

Published in the Journal of Clinical Anesthesia, results from the two-phase, 250 patient pilot study show clinicians found a majority (82%) of the alarms from the wireless and wearable Portrait Mobile monitoring solution to be informative or useful to optimize patient care in medical-surgical units.1 Study findings suggest that continuous monitoring helps provide critical information to clinicians, enabling them to intervene effectively...Read more


CareMax Reaches Agreements to Sell Management Services Organization and Core Centers’ Assets

November 17
Last Trade: 0.54 0.00 0.00

Revere Medical Enters into Agreement to Acquire CareMax’s Management Services Organization Agreement in Principle Reached with “Stalking Horse” for Core Centers’ Assets Sale Transactions to be Implemented Through an Expedited Prearranged Chapter 11 Plan Supported by 100% of CareMax’s Secured Lenders CareMax Secures $30.5 Million in Debtor in Possession Financing to Support Operations and Continuing Provision of Healthcare Services...Read more


Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st

November 14
Last Trade: 0.18 0.006 3.45

BROOMFIELD, CO / ACCESSWIRE / November 14, 2024 / Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq:ACON) (Nasdaq:ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced its participation at the upcoming Virtual Investor Summit Microcap Event on November 21st. The Company will be...Read more


Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment

November 14
Last Trade: 67.48 0.00 0.00

Clarity Precision Grip Attachments are fully cured, pre-loaded and precisely resemble the digital treatment plan after bonding ST. PAUL, Minn., Nov. 14, 2024 /PRNewswire/ -- This month, Solventum (NYSE: SOLV), formerly 3M Health Care, officially launched an anticipated innovation in aligner treatment, 3M™ Clarity™ Precision Grip Attachments. Available exclusively with 3M™ Clarity™ Aligners, Clarity Precision Grip...Read more


Progyny to Present at Jefferies London Healthcare Conference

November 14
Last Trade: 15.74 -0.10 -0.63

NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 8:00 a.m. GMT (3:00 a.m. EST). A live audiocast and...Read more


LifeWallet Announces Third Quarter 2024 Financial Results

November 14
Last Trade: 1.59 0.00 0.00

MIAMI, Nov. 14, 2024 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. d/b/a LifeWallet (NASDAQ: LIFW) (“LifeWallet,” or the “Company”), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, today announced financial results for the quarter ended September 30, 2024. LifeWallet Chief Executive Officer, John H. Ruiz, said, “From additional settlements to the processing of additional claims data, we...Read more


VitalHub Reports Third Quarter 2024 Results

November 13
Last Trade: 11.22 -0.29 -2.52

Annual Recurring Revenue (ARR) ⁽¹⁻²⁾ up 25% YoY to $53.5 million  Total Revenue up 25% YoY to $16.5 million  Adjusted EBITDA ⁽²⁾ up 33% YoY to $4.6 million TORONTO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Vitalhub Corp. (the “Company” or “VitalHub”) (TSX:VHI) (OTCQX:VHIBF) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and Analysis report for the three and nine...Read more


OptimizeRx Reports Third Quarter 2024 Financial Results

November 13
Last Trade: 5.47 0.23 4.40

Q3 revenue of $21.3 million, increasing 30% year-over-year Q3 gross profit increased 37% year-over-year to $13.4 million with a gross margin of 63% Won 5 DAAP deals during Q3 WALTHAM, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients,...Read more


GE HealthCare Receives FDA Clearance for Head-Only SIGNA MAGNUS 3.0T MRI System

November 13
Last Trade: 81.90 0.00 0.00

New MRI technology aims to advance neuroimaging and biomarker research CHICAGO / Nov 13, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS,i a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner. This system offers new capabilities for both clinical imaging and neuroscience with the potential to aid in the detection of neurological, oncological,...Read more


Accolade To Present at Upcoming Investor Conferences

November 13
Last Trade: 3.69 0.15 4.10

SEATTLE, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor events. A webcast will be available at ir.accolade.com and a replay will be available for 90 days. Stephens Annual Investment Conference | NASH2024 in Nashville on Wednesday, November 20 at 9:00 am CT CG MedTech, Diagnostics and Digital Health & Services Forum in New York on...Read more


Forian Announces Third Quarter 2024 Financial Results

November 13
Last Trade: 2.05 0.00 0.00

NEWTOWN, Pa., Nov. 13, 2024 (GLOBE NEWSWIRE) -- NEWTOWN, Pa.  Forian Inc. (Nasdaq: FORA), a leading provider of data science driven information and analytics solutions to the life science, healthcare and financial services industries, today announced results for the quarter ended September 30, 2024. “While this quarter’s revenue remained steady, our team’s commitment to driving long-term value has resulted in progress in our...Read more


iCAD Reports Financial Results for Third Quarter Ended September 30, 2024

November 13
Last Trade: 1.89 0.01 0.53

NASHUA, N.H., Nov. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three and nine months ended September 30, 2024.  Third Quarter 2024 Highlights (Year over Year Performance): Total ARR was...Read more


Ontrak Health Announces 2024 Third Quarter Financial Results

November 13
Last Trade: 1.62 -0.04 -2.29

Q3 Revenue of $2.6 million, down 31% year-over-year Q3 Operating loss of $(5.1) million, a 26% increase year-over-year Q3 Adjusted EBITDA of $(3.3) million, a 24% decline year-over-year Company announces expansion of behavioral health solutions with Sentara Health for Commercial and Marketplace members Company begins enrollment of new members into Ontrak's WholeHealth+ solution under a new contract with a large northeast regional...Read more


Progyny Announces Third Quarter 2024 Results

November 12
Last Trade: 15.74 -0.10 -0.63

Sales Season Yields Over 80 New Clients, 1.1 Million New Covered Lives Selected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner 1.5 Million Lives Adopt Newest Services in Maternity and/or Menopause Programs in 2025 NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a transformative fertility, family building and women's health benefits...Read more


GE HealthCare Announces Initiative to Help Address Radiologic Technologist Shortage

November 12
Last Trade: 81.90 0.00 0.00

Factors impacting today’s critical shortage of radiologic technologists include clinician burnout, the impact of COVID and COVID-related policies, and demand for radiologic technologists outpacing today’s number of trained clinicians. GE HealthCare and AMN Healthcare are working together to enable training and development of the next generation of radiologic technologists to help address this critical clinician shortage and support...Read more


iCAD's ProFound Detection Version 4.0 Gains FDA Clearance

November 12
Last Trade: 1.89 0.01 0.53

NASHUA, N.H., Nov. 12, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader in clinically proven AI-powered cancer detection solutions, announced today that its ProFound Detection Version 4.0 for Digital Breast Tomosynthesis (DBT) has received clearance from the U.S. Food and Drug Administration (FDA). This next-generation AI solution, trained using advanced deep learning convolutional neural...Read more


Schrödinger Reports Third Quarter 2024 Financial Results

November 12
Last Trade: 22.06 0.38 1.75

Schrödinger to Receive $150 Million Upfront for New Multi-Target Collaboration with Novartis Third Quarter Total Revenue of $35.3 Million, Software Revenue of $31.9 Million Updates 2024 Financial Guidance NEW YORK / Nov 12, 2024 / Business Wire / Schrödinger, Inc. (Nasdaq: SDGR) today announced financial results for the third quarter of 2024 and provided a business update. In a separate press release issued earlier today, Schrödinger...Read more


Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis

November 12
Last Trade: 22.06 0.38 1.75

Schrödinger to receive $150 million upfront and eligible to receive up to approximately $2.3 billion in milestone payments plus royalties Expanded multi-year software agreement enables technology deployment at significant scale across Novartis’s global research organization Schrödinger to host third quarter 2024 financial results webcast today at 8:00 a.m. ET NEW YORK / Nov 12, 2024 / Business Wire / Schrödinger, Inc. (Nasdaq: SDGR)...Read more


HEALWELL Reports Record Revenue and Increased Customer Activity from Pharmaceutical Partners in Q3-2024

November 12
Last Trade: 1.88 0.03 1.62

HEALWELL achieved record quarterly revenue from continuing operations of $13.7 million in Q3-2024, 738% higher than the $1.6 million generated in Q3-2023 and 153% higher than the $5.4 million generated in Q2-2024. Quarterly revenues were driven by HEALWELL completing the acquisitions of BioPharma Services Inc. and VeroSource Solutions Inc. during Q3-2024. Management maintains a positive outlook and based on current M&A pipeline...Read more


HealthEquity Announces Retirement of CEO Jon Kessler; Scott Cutler Appointed Successor

November 12
Last Trade: 94.92 -6.08 -6.02

DRAPER, Utah, Nov. 12, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA") custodian, today announced that after leading the company for more than 15 years, Jon Kessler, President and Chief Executive Officer, has decided to retire effective January 6, 2025. Mr. Kessler will remain a director and act a special advisor to the Company through April...Read more


CareCloud Reports Third Quarter 2024 Results

November 12
Last Trade: 4.51 0.17 3.92

Pays Off Credit Line, Plans to Resume Preferred Dividends in Q1 2025 SOMERSET, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced financial and operational results for the quarter ended September 30, 2024 including that it has fully paid its credit line and that it plans...Read more


Sign Up To Get Daily Life Science Stock News

Please review our Disclaimer and Privacy Policy before subscribing.

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

COPYRIGHT ©2023 HEALTH STOCKS HUB